Compare, Analyse IPCA Labs with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ACTAVIS (US) - Comparison Results

IPCA LABS     Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   ACTAVIS
EQUITY SHARE DATA
    IPCA LABS
Mar-19
ACTAVIS
Dec-18
IPCA LABS/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,04214,247-   
Low Rs5909,557-   
Sales per share (Unadj.) Rs298.63,494.9-  
Earnings per share (Unadj.) Rs35.0-1,125.7-  
Cash flow per share (Unadj.) Rs49.4368.3-  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs247.114,414.7-  
Shares outstanding (eoy) m126.35332.60-   
Bonus/Rights/Conversions ESOS--  
Price / Sales ratio x2.73.4 80.2%   
Avg P/E ratio x23.3-10.6 -220.5%  
P/CF ratio (eoy) x16.532.3 51.1%  
Price / Book Value ratio x3.30.8 399.9%  
Dividend payout %8.60-   
Avg Mkt Cap Rs m103,1083,958,701 2.6%   
No. of employees `00013.416.9 79.5%   
Total wages/salary Rs m7,8740-   
Avg. sales/employee Rs Th2,807.068,780.9 4.1%   
Avg. wages/employee Rs Th585.80-   
Avg. net profit/employee Rs Th329.0-22,154.4 -1.5%   
INCOME DATA
Net Sales Rs m37,7321,162,397 3.2%  
Other income Rs m57722,229 2.6%   
Total revenues Rs m38,3091,184,626 3.2%   
Gross profit Rs m6,90130,461 22.7%  
Depreciation Rs m1,824496,899 0.4%   
Interest Rs m18967,077 0.3%   
Profit before tax Rs m5,465-511,287 -1.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0130,399 0.0%   
Tax Rs m1,042-6,479 -16.1%   
Profit after tax Rs m4,422-374,409 -1.2%  
Gross profit margin %18.32.6 697.9%  
Effective tax rate %19.11.3 1,505.2%   
Net profit margin %11.7-32.2 -36.4%  
BALANCE SHEET DATA
Current assets Rs m23,778476,754 5.0%   
Current liabilities Rs m10,975421,753 2.6%   
Net working cap to sales %33.94.7 717.1%  
Current ratio x2.21.1 191.7%  
Inventory Days Days10420 529.8%  
Debtors Days Days6666 99.4%  
Net fixed assets Rs m20,368131,577 15.5%   
Share capital Rs m2530-   
"Free" reserves Rs m30,9710-   
Net worth Rs m31,2244,794,344 0.7%   
Long term debt Rs m1,4091,688,262 0.1%   
Total assets Rs m45,5077,494,650 0.6%  
Interest coverage x30.0-6.6 -452.4%   
Debt to equity ratio x00.4 12.8%  
Sales to assets ratio x0.80.2 534.6%   
Return on assets %10.1-4.1 -247.1%  
Return on equity %14.2-7.8 -181.4%  
Return on capital %17.3-4.8 -357.9%  
Exports to sales %45.90-   
Imports to sales %16.60-   
Net fx Rs m11,0420-   
CASH FLOW
From Operations Rs m4,923415,281 1.2%  
From Investments Rs m-1,563228,143 -0.7%  
From Financial Activity Rs m-1,832-712,746 0.3%  
Net Cashflow Rs m1,528-68,977 -2.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 73.63 Rs / USD

Compare IPCA LABS With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare IPCA LABS With: AUROBINDO PHARMA  VENUS REMEDIES  DR. REDDYS LAB  DR. DATSONS LABS  DIVIS LABORATORIES  



Today's Market

Sensex Opens 350 Points Higher; Dr Reddy's Lab & Tata Steel Top Gainers(09:30 am)

Asian stock markets rose today amid speculation that interest rates will remain low due to receding inflationary pressure.

Related Views On News

IPCA LABS Announces Quarterly Results (3QFY21); Net Profit Up 32.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, IPCA LABS has posted a net profit of Rs 3 bn (up 32.2% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away? (Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

IPCA LABS SHARE PRICE


May 10, 2021 10:51 AM

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS - SUVEN LIFE SCIENCES COMPARISON

COMPARE IPCA LABS WITH

FEATURED VIDEOS

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

More Featured Videos

MARKET STATS